Suvretta Capital Management, LLC 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-21 09:07 am Purchase | 2025-08-13 | 13G | Compass Therapeutics, Inc. CMPX | Suvretta Capital Management, LLC | 14,101,159 8.200% | 6,951,666 (+97.23%) | Filing |
| 2025-08-13 8:21 pm Purchase | 2025-06-30 | 13G | Compass Therapeutics, Inc. CMPX | Suvretta Capital Management, LLC | 7,149,493 5.200% | 7,149,493 (New Position) | Filing |